Back Haleon German Haleon Spanish Haleon French Haleon ID ヘイリオン Japanese Haleon Malay Haleon Dutch Haleon Ukrainian 赫力昂 Chinese
 | |
| Company type | Public limited company |
|---|---|
| ISIN | GB00BMX86B70 |
| Industry | |
| Predecessors | |
| Founded | 18 July 2022 |
| Headquarters | Weybridge, England, UK |
Area served | Worldwide |
Key people |
|
| Products |
|
| Brands | |
| Revenue |  £11,302 million (2023)[1] |
| £1,996 million (2023)[1] | |
 £1,111 million (2023)[1] | |
| Total assets | £34,055 million (2023)[1] |
| Total equity | £16,729 million (2023)[1] |
Number of employees | 24,000 (2023)[2] |
| Website | www |
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England.[3] It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers and Centrum vitamins.[4] The company is a global leader in over the counter medicines with a 7.3 percent market share.[5]
Haleon was established on 18 July 2022 as a corporate spin-off from GSK.[6]
Sir David Lewis is chairman, with Brian McNamara as CEO.[7] Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Annual sales amounted to around £10 billion across 120 markets in 2020.[5]
- ^ a b c d e "Annual results 2023" (PDF). Haleon. Retrieved 29 February 2024.
- ^ "Haleon plots massive layoffs in UK and beyond to save costs: report". Fierce Pharma. 13 July 2023. Retrieved 11 February 2024.
- ^ "GSK announces independent Consumer Healthcare company is to be called Haleon | GSK". www.gsk.com. 22 February 2022. Retrieved 2023-02-21.
- ^ Ralph, Alex (2 July 2022). "GlaxoSmithKline prepares to get back to basics with historic break-up". The Times. Retrieved 4 July 2022.
- ^ a b Cornell, Joe (15 July 2021). "GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022". Forbes. Retrieved 10 June 2022.
- ^ "Prospectus" (PDF). GSK plc. p. 15. Archived from the original (PDF) on 1 June 2022. Retrieved 10 June 2022.
- ^ Kleinman, Mark (3 May 2022). "GSK's £45bn Panadol and Sensodyne-maker Haleon in talks to hire banks". Sky News. Retrieved 10 June 2022.